WisdomTree BioRevolution UCITS ETF – USD Acc

Issuer: WisdomTree

Asset Class: Equity

TER: 45bps

Trading Currency: GBX

Pays Income: False

Listing Date: 09 Dec 2021

Ticker: WBIO

ISIN: IE000O8KMPM1

This actively managed fund offers targeted exposure to the 'Biorevolution,' a rapidly advancing field at the intersection of biology and technology. It aims to capture the long-term growth potential of companies leading innovation in areas such as genomics, gene therapy, synthetic biology, and biomanufacturing. The portfolio is constructed by a team of scientific experts and investment professionals, focusing on identifying companies with strong intellectual property, disruptive technologies, and significant market potential. The strategy involves a deep-dive analysis into the science behind the companies, ensuring investments are based on fundamental research and a clear understanding of the technological landscape.

The portfolio is diversified across various sub-sectors within the biotechnology and healthcare industries, including companies developing novel diagnostics, targeted therapies, and advanced agricultural technologies. By investing in both publicly listed pioneers and smaller, high-growth innovators, the fund provides a comprehensive approach to this transformative theme. This strategy is designed for investors seeking to participate in the significant advancements in life sciences, which are driven by an aging global population, increasing healthcare spending, and continuous breakthroughs in research and development. The fund's focus on companies creating sustainable solutions also aligns with a growing demand for investments that can generate both financial returns and positive societal impact.